{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:52:11Z","timestamp":1791928331965,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.kint.2020.02.025","type":"journal-article","created":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T02:49:39Z","timestamp":1585363779000},"page":"498-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["DNAJB9-positive monotypic fibrillary glomerulonephritis is not associated with monoclonal gammopathy in the vast majority of patients"],"prefix":"10.1016","volume":"98","author":[{"given":"Samar M.","family":"Said","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam Priya","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn D.","family":"Cornell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Fidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren Hernandez","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingchuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samih H.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2020.02.025_bib1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/j.ajkd.2013.03.031","article-title":"Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients","volume":"62","author":"Javaugue","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2020.02.025_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ekir.2017.07.017","article-title":"DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis","volume":"3","author":"Nasr","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2020.02.025_bib3","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1046\/j.1523-1755.2003.00853.x","article-title":"Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features","volume":"63","author":"Rosenstock","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.02.025_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000455390","article-title":"Clinical features and outcomes of a racially diverse population with fibrillary glomerulonephritis","volume":"45","author":"Payan Schober","year":"2017","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2020.02.025_bib5","first-page":"103","article-title":"Monoclonal immunoglobulin G1-kappa fibrillary glomerulonephritis","volume":"11","author":"Grove","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1016\/j.kint.2020.02.025_bib6","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/ki.1992.433","article-title":"Clinical and pathologic features of fibrillary glomerulonephritis","volume":"42","author":"Iskandar","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.02.025_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.kint.2019.03.021","article-title":"New developments in the diagnosis of fibrillary glomerulonephritis","volume":"96","author":"Nasr","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.02.025_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0272-6386(12)70138-5","article-title":"Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy","volume":"22","author":"Fogo","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2020.02.025_bib9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ekir.2019.04.013","article-title":"Fibrillary glomerulonephritis: an update","volume":"4","author":"Rosenstock","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2020.02.025_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group","volume":"15","author":"Leung","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2020.02.025_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1681\/ASN.2017030306","article-title":"DnaJ heat shock protein family B member 9 is a novel biomarker for fibrillary GN","volume":"29","author":"Dasari","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.02.025_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1681\/ASN.2017050566","article-title":"DnaJ homolog subfamily B member 9 is a putative autoantigen in fibrillary GN","volume":"29","author":"Andeen","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.02.025_bib13","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2215\/CJN.03870319","article-title":"Fibrillary glomerulonephritis: clinicopathologic features and atypical cases from a multi-institutional cohort","volume":"14","author":"Andeen","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.02.025_bib14","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1681\/ASN.2015060612","article-title":"Mayo Clinic\/Renal Pathology Society Consensus report on pathologic classification, diagnosis, and reporting of GN","volume":"27","author":"Sethi","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.02.025_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.kint.2018.11.008","article-title":"Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"95","author":"Rovin","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.02.025_bib16","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.ekir.2018.07.008","article-title":"Paraffin immunofluorescence: a valuable\u00a0ancillary technique in renal pathology","volume":"3","author":"Nasr","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2020.02.025_bib17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2215\/CJN.08300910","article-title":"Fibrillary glomerulonephritis: a report of 66 cases from a single institution","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.02.025_bib18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1053\/j.ajkd.2019.01.032","article-title":"Heavy chain fibrillary glomerulonephritis: a case report","volume":"74","author":"Nasr","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2020.02.025_bib19","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/sj.ki.5001990","article-title":"Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies","volume":"70","author":"Nasr","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.02.025_bib20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/modpathol.2015.1","article-title":"Paraffin immunofluorescence in the renal pathology laboratory: more than a salvage technique","volume":"28","author":"Messias","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.kint.2020.02.025_bib21","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1681\/ASN.2015020185","article-title":"Light chain proximal tubulopathy: clinical and pathologic characteristics in the modern treatment era","volume":"27","author":"Stokes","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.02.025_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ki.2013.548","article-title":"Membranous-like glomerulopathy with masked IgG kappa deposits","volume":"86","author":"Larsen","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.02.025_bib23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ki.2015.195","article-title":"Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits","volume":"88","author":"Larsen","year":"2015","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253820302672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253820302672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:56:25Z","timestamp":1758761785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253820302672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0085253820302672"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2020.02.025","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNAJB9-positive monotypic fibrillary glomerulonephritis is not associated with monoclonal gammopathy in the vast majority of patients","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2020.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}